Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. (Q44717852)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment. |
scientific article |
Statements
Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment (English)
Joachim F Wernicke
Thomas Spencer
Scott A West
Albert J Allen
John Heiligenstein
Denái Milton
Dustin Ruff
W Jeffrey Brown
Douglas Kelsey
David Michelson
1 February 2004